Treating Nosebleeds in the ER with Powder Tranexamic Acid
Treatments studied
Part of Ear, nose & throat clinical trials.
This trial tests whether a powder form of tranexamic acid can stop nosebleeds faster in people who come to the emergency room with active bleeding. It may offer a new option if standard treatments don't work well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are able to understand and sign a consent form.
- You are willing to follow all study steps and be available for the whole study.
- You are coming to the emergency room with a nosebleed that is still actively bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments for a nosebleed (epistaxis) that won't stop with simple pressure: tranexamic acid, a medicine that helps blood clot, versus Blood Stopper (Ankaferd), a plant-based product that also stops bleeding. The goal is to see which works better in the emergency room.
This trial tests whether giving tranexamic acid at different times during heart surgery can reduce blood loss and the risk of seizures. It may help patients who need certain types of heart surgery with a heart-lung machine.
This Phase 1 study tests whether tranexamic acid (a medicine that helps reduce bleeding) can lessen bleeding, swelling, and bruising after open rhinoplasty. You may be asked to take it around the time of surgery if you meet safety and lab criteria.
This trial tests if tranexamic acid (a medicine that helps blood clot) reduces bleeding and bruising during nose reconstruction after skin cancer removal. It is for adults having a specific type of flap repair on their nose.
This study looks at different management strategies for severe nosebleeds when the initial packing method has not worked for over 48 hours. It also measures the cost/benefit of these approaches to help improve care.
This trial is testing a specific dose of a medicine called tranexamic acid (which helps control bleeding) along with a certain way of giving pain medicine during nose surgery. It looks at how these treatments affect bleeding and recovery.
Hear when a new Epistaxis Nosebleed trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.